Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012, Article ID 451205, 6 pages
Research Article

Factors Contributing to the Utilization of Adult Mental Health Services in Children and Adolescents Diagnosed with Hyperkinetic Disorder

1Department of Psychiatry. IIS-Fundación Jiménez Díaz, Autonoma University, 28040 Madrid, Spain
2Centro de Investigación Biomédica en Red (CIBERSAM), 28007 Madrid, Spain
3Departament of Psiquiatry, Hospital Ramón y Cajal, Alcalá University, 28034 Madrid, Spain
4Department of Mental Health, Madrid Regional Health Council, 28013 Madrid, Spain
5Department of Psychiatry, Hospital Doce de Octubre, Complutense University, 28041 Madrid, Spain
6Department of Psychiatry, New York State Psychiatric Institute, Columbia University, New York, NY 10032, USA

Received 28 October 2011; Accepted 25 December 2011

Academic Editors: J.-Y. Chen and R. Corcoran

Copyright © 2012 Hilario Blasco-Fontecilla et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Objectives. To examine whether age of First diagnosis, gender, psychiatric comorbidity, and treatment modalities (pharmacotherapy or psychotherapy) at Child and Adolescent Mental Health Services (CAMHS) moderate the risk of Adult Mental Health Services (AMHS) utilization in patients diagnosed with hyperkinetic disorder at CAMHS. Methods. Data were derived from the Madrid Psychiatric Cumulative Register Study. The target population comprised 32,183 patients who had 3 or more visits at CAMHS. Kaplan-Meier curves were used to assess survival data. A series of logistic regression analyses were performed to study the role of age of diagnosis, gender, psychiatric comorbidity, and treatment modalities. Results. 7.1% of patients presented with hyperkinetic disorder at CAMHS. Compared to preschool children, children and adolescents first diagnosed with hyperkinetic disorder at CAMHS were more likely to use AMHS. Female gender and comorbidity with affective disorders, schizophrenia, schizotypal and delusional disorders increased the risk of use of AMHS. Pharmacological or combined treatment of hyperkinetic disorder diagnosed at CAMHS was associated with increased risk of use at AMHS. Conclusions. Older age of first diagnosis, female gender, psychiatric comorbidity, and pharmacological treatment at CAMHS are markers of risk for the transition from CAMHS to AMHS in patients with hyperkinetic disorder diagnosed at CAMHS.